DNA topoisomerase II is a homodimeric molecular machine that couples ATP usage to the transport of one DNA segment through a transient break in another segment. In the presence of a nonhydrolyzable ATP analog, the enzyme is known to promote a single turnover of DNA transport. Current models for the enzyme's mechanism based on this result have hydrolysis of two ATPs as the last step, used only to reset the enzyme for another round of reaction. Using rapid-quench techniques, topoisomerase II recently was shown to hydrolyze its two bound ATPs in a strictly sequential manner. This result is incongruous with the models based on the nonhydrolyzable ATP analog data. Here we present evidence that hydrolysis of one ATP by topoisomerase II precedes, and accelerates, DNA transport. These results indicate that important features of this enzyme's mechanism previously have been overlooked because of the reliance on nonhydrolyzable analogs for studying a single reaction turnover. A model for the mechanism of topoisomerase II is presented to show how hydrolysis of one ATP could drive DNA transport.T ype II DNA topoisomerases are ubiquitous enzymes essential for the unlinking of intertwined chromosomes, chromosomal condensation͞decondensation, and manipulation of DNA supercoiling (1, 2). These enzymes catalyze the ATP-dependent transport of one segment of DNA through a transient, enzymemediated break in a second DNA segment (for recent reviews, see refs. 3 and 4). The eukaryotic topoisomerase II enzymes are homodimers, with a monomer molecular mass of Ϸ160-180 kDa, making them relatively simple macromolecular machines for studying the coupling of ATP usage to complex protein movements. The N-terminal half of the enzyme is homologous to Escherichia coli gyrase B and contains the ATPase active site; the C-terminal half is homologous to gyrase A and contains the active site tyrosine for DNA cleavage and the primary dimerization interface. In addition to being mechanistically fascinating, the prokaryotic and eukaryotic members of this enzyme family are the targets of numerous antibiotic and anticancer drugs, respectively (5-7).The mechanism of topoisomerase II is known to involve several steps and associated protein conformational changes (reviewed in ref. 4). The enzyme binds a segment of DNA, the gate or G segment. Both strands of this DNA segment are cleaved and religated by a pair of active site tyrosines, one in each monomer of the dimer. The cleavage reaction results in a four-base staggered break in the DNA, with an enzyme monomer covalently attached to each 5Ј phosphate. Upon binding ATP, the amino-terminal ATPase domains of the enzyme dimerize, capturing a second segment of DNA, the transport or T segment, within the enzyme clamp. The ends of the cleaved G segment are separated, and the T segment is transported through the opening. The gate in the G segment is closed. The T segment is transported out of the topoisomerase, most likely through the C-terminal dimerization interface. The amino terminal dimerization interface re...